Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Traveller’s Diarrhoea Treatment Market: By Drug Type: Oral Rehydration Therapy (ORS), Antidiarrhoeal Agents, Vaccines/Prophylactics; By Pathogen; By Age; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Traveller’s Diarrhoea Treatment Market Outlook

The global traveller’s diarrhoea treatment market is expected to grow at a CAGR of 6% in the forecast period of 2021-2026.

 

Global Traveller’s Diarrhoea Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Huge Number of Market Players to Aid the Market Growth of Traveller’s Diarrhoea Treatment

The market growth of traveller’s diarrhoea treatment is being driven by the huge number of market players that offer significant competition. The market is stimulated by the growing emphasis on the adoption of the latest technological advancement by manufacturers of drugs, along with offering specialized distribution channels for drugs for the treatment of traveller’s diarrhoea. Moreover, the latest product development to formulate specialized drugs and vaccines for the treatment of traveller’s diarrhoea with preventive effect, is shifting the market scenario for the treatment of traveller’s diarrhoea. In addition, the launch of new vaccine produced by the manufacturer is predicted to boost competition among the manufacturers of traveller’s diarrhoea treatment industry, further encouraging market growth.

 

Traveller’s Diarrhoea Treatment: Industry Definition and Segmentation

Traveller’s diarrhoea treatment is referred to a treatment for a condition in which intestine and stomach are infected, majorly caused by the unsanitary conditions while handling edibles. Traveller’s diarrhoea is characterised by frequent lose stools and abdominal cramps triggered by the consumption of contaminated food and unfiltered water.

 

Global Traveller’s Diarrhoea Treatment Market By Age

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of drug type, the market is divided into:

  • Oral Rehydration Therapy (ORS)
  • Antidiarrhoeal Agents
  • Vaccines/Prophylactics
  • Others

Antidiarrhoeal agents are further divided into antibiotics, azithromycin, ciprofloxacin, quinolones, rifaximin, among others.

By pathogen, the industry is segmented into:

  • Bacteria
  • Viruses
  • Protozoa 
  • Others

Based on age, the industry is categorized into:

  • Adult
  • Children

On the basis of distribution channel, the industry is segregated into:

  • Hospital Pharmacies
  • Drug Store
  • Online

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Traveller’s Diarrhoea Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Booming Tourism Business in the Developing Countries to Aid the Market Growth of Traveller’s Diarrhoea Treatment

The market growth of traveller’s diarrhoea treatment is being driven by the rising number of regular flyers and booming tourism business in developing countries. Further, the traveller’s diarrhoea treatment is crucial to the traveller’s itinerary and contributes significantly to the patient’s wellbeing while travelling abroad. In addition, the growing awareness among the masses about the traveller’s diarrhoea treatment is expected to provide impetus to the market growth of traveller’s diarrhoea treatment. Moreover, the ease and convenience in acquiring the treatment drugs for traveller’s diarrhoea, along with the availability of over the counter medications is expected to provide lucrative opportunities for the growth of traveller’s diarrhoea treatment industry.

 

Key Industry Players in the Global Traveller’s Diarrhoea Treatment Market

The report gives a detailed analysis of the following key players in the global traveller’s diarrhoea treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Bausch Health Companies Inc.
  • COSMO Pharmaceuticals
  • Immuron Ltd.
  • Sanofi SA
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Traveller’s Diarrhoea Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Traveller’s Diarrhoea Treatment Historical Market (2016-2020) 
    8.3    Global Traveller’s Diarrhoea Treatment Market Forecast (2021-2026)
    8.4    Global Traveller’s Diarrhoea Treatment Market by Drug Type
        8.4.1    Oral Rehydration Therapy (ORS)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Antidiarrhoeal Agents
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Antibiotics
                    8.4.2.4.1.1    Market Share
                    8.4.2.4.1.2    Historical Trend (2016-2020)
                    8.4.2.4.1.3    Forecast Trend (2021-2026)
                8.4.2.4.2    Azithromycin
                    8.4.2.4.2.1    Market Share
                    8.4.2.4.2.2    Historical Trend (2016-2020)
                    8.4.2.4.2.3    Forecast Trend (2021-2026)
                8.4.2.4.3    Ciprofloxacin
                    8.4.2.4.3.1    Market Share
                    8.4.2.4.3.2    Historical Trend (2016-2020)
                    8.4.2.4.3.3    Forecast Trend (2021-2026)
                8.4.2.4.4    Quinolones
                    8.4.2.4.4.1    Market Share
                    8.4.2.4.4.2    Historical Trend (2016-2020)
                    8.4.2.4.4.3    Forecast Trend (2021-2026)
                8.4.2.4.5    Rifaximin
                    8.4.2.4.5.1    Market Share
                    8.4.2.4.5.2    Historical Trend (2016-2020)
                    8.4.2.4.5.3    Forecast Trend (2021-2026)
                8.4.2.4.6    Others
        8.4.3    Vaccines/Prophylactics
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Others
    8.5    Global Traveller’s Diarrhoea Treatment Market by Pathogen
        8.5.1    Bacteria
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Viruses
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Protozoa 
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Others
    8.6    Global Traveller’s Diarrhoea Treatment Market by Age
        8.6.1    Adult
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Children
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
    8.7    Global Traveller’s Diarrhoea Treatment Market by Distribution Channel
        8.7.1    Hospital Pharmacies
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Drug Store
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
    8.8    Global Traveller’s Diarrhoea Treatment Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Bausch Health Companies Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    COSMO Pharmaceuticals
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Immuron Ltd.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Sanofi SA
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Traveller’s Diarrhoea Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Drug Type (USD Billion), 2016-2020
3.    Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Drug Type (USD Billion), 2021-2026
4.    Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Pathogen (USD Billion), 2016-2020
5.    Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Pathogen (USD Billion), 2021-2026
6.    Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Age (USD Billion), 2016-2020
7.    Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Age (USD Billion), 2021-2026
8.    Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
9.    Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
10.    Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Global Traveller’s Diarrhoea Treatment Market Structure

Key Questions Answered in the Report

The global traveller’s diarrhoea treatment market is projected to grow at a CAGR of 6% between 2021 and 2026.

The major drivers of the industry such as booming tourism business, rising awareness about the disease, rising demand from the developing regions, and huge number of market players are expected to aid the market growth.

The key market trend guiding the growth of the industry includes the availability of over the counter medications, consequently offering lucrative opportunities for the market growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading drug types in the market are oral rehydration therapy (ORS), antidiarrhoeal agents, and vaccines/prophylactics, among others.

The major pathogen segments in the industry are bacteria, viruses, and protozoa, among others.

The significant age segments in the market are adult and children.

The leading distribution channels in the industry are hospital pharmacies, drug store, and online.

The major players in the industry are Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., and Sanofi SA, among others.

Analyst Review

The global traveller’s diarrhoea treatment market is being driven by the rising tourism sector. Aided by the growing awareness about the disease, the market is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug type, the market is segmented into oral rehydration therapy (ORS), antidiarrhoeal agents, and vaccines/prophylactics, among others. On the basis of pathogen, the industry is divided into bacteria, viruses, and protozoa, among others. By age, the market is categorised into adult and children. Based on distribution channel, the industry is segmented into hospital pharmacies, drug store, and online. The major regional markets for traveller’s diarrhoea treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., and Sanofi SA, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Anti-Snoring Treatment Market Report and Forecast 2021-2026


Global Haemophilia Treatment Market Report and Forecast 2021-2026



Global Tinea Corporis Treatment Market Report and Forecast 2021-2026


Global Xerostomia Treatment Market Report and Forecast 2021-2026


NEWSLETTER